Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine

Endocrinology

Volumn 143, Issue 4, 2002, Pages 1327-1336

  Dicky Lai Yin, T S E ^a   Pang, Ronald Ting Kai ^a   Wong, Anderson O N Lam ^a   Chan, Siu Ming ^a   Vaudry, Hubert ^b   Chow, Billy Kwok Chong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; HELODERMIN; HORMONE PRECURSOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MESSENGER RNA; NEUROPEPTIDE RECEPTOR; PEPTIDE HISTIDINE ISOLEUCINE; PEPTIDE HISTIDINE VALINE; POLYADENYLATED RNA; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CHO CELL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GALLBLADDER; GENE EXPRESSION; GOLDFISH; HYPOPHYSIS FUNCTION; INTESTINE; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TISSUE DISTRIBUTION;

EID: 0036212655     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.143.4.1327     Document Type: Article

References (55)

1. Concentrations and distribution of vaso-active intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse
2. All prepro-VIP-derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen
3. Expression of prepro-VIP derived peptides in the gastrointestinal tract of normal, hypothyroid and hyperthyroid rats
4. Peptide histidine methionine (PHM) and the human male genitalia
5. Peptide histidine methionine and vasoactive intestinal peptide: Occurrence and relaxant effect in the human female reproductive tract
6. Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology
7. Co-existence and co-secretion of the structurally related peptides VIP and PHI
8. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome
9. Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum
10. Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical and diencephalic cells in dispersed cell culture
11. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro
12. Commonalities in vasoactive intestinal peptide and peptide N-terminal histidine C-terminal isoleucine stimulation of N-acetyltransferase activity in the rat pineal
13. Cerebral vascular effects of peptide histidine methionine in canine and bovine species
14. Effect of vasoactive intestinal polypeptide on active and passive transport in the human jejunum
15. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets
16. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
17. The VIP2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide
18. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
19. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI). Vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat
20. PHI preferentially binds to VIP receptors in normal rat tissues
21. Evidence that vascular actions of PHI are mediated by a VIP-preferring receptor
22. Effects of preoptic injections of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide and PHI on the secretion of luteinizing hormone and prolactin in ovariectomized estrogen-primed rats
23. Peptide histidine isoleucine and vasoactive intestinal polypeptide cause relaxation of opossum internal anal sphincter via two distinct receptors
24. Peptide histidine isoleucine-induced elevations in ACTH and corticosterone in the rat
25. High affinity peptide histidine isoleucine-preferring receptors in rat liver
26. Demonstration of receptors specific for peptide N-terminal histidine and C-terminal isoleucine (PHI) using rat PHI and rat dispersed pineal cells
27. 1)
28. Binding sites for peptide-histidine-isoleucine (PHI) on rat insulinoma-derived RINm5F cells
29. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells
30. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation
31. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
32. Molecular evolution of vertebrate VIP receptors and functional characterization of a VIP receptor from goldfish Carassius auratus
33. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: Immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor
34. Identification and characterization of a receptor from goldfish specific for a teleost growth hormone-releasing hormone-like peptide
35. Molecular cloning of a cDNA encoding proglucagon from goldfish, Carassius auratus
36. 2 receptor from the frog Rana tigrina rugulosa
37. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts
38. Somatostatin-, vasoactive intestinal peptide-, and granulin-like peptides isolated from intestinal extracts of goldfish, Carassius auratus
39. Mechanism of C-terminal amide formation by pituitary enzymes
40. Evidence for alternative splicing of the chicken vasoactive intestinal polypeptide gene transcript
41. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
42. Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat
43. Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion
44. Alternative splicing in the control of gene expression
45. 2 receptors
46. Isolation, characterization, and pharmacological actions of peptide histidine valine 42, a novel prepro-vasoactive intestinal peptide-derived peptide
47. Peptide histidine isoleucine (PHI) and the Verner-Morrison syndrome
48. Peptide histidine valine: Its haemodynamic actions and pharmacokinetics in man differ from those of vasoactive intestinal peptide and peptide histidine methionine
49. Is VIP really the main contributor to the watery diarrhea in patients with VIP-secreting tumors?
50. Gene expression and transcript size of the prepropeptide VIP/PHM-27 in normal human tissue
51. Effect of vasoactive intestinal polypeptide on gastric acid secretion and mucosal blood flow in the Atlantic cod, Gadus morhua
52. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
53. Peptide histidine methionine may be a prolactin-releasing hormone in humans
54. Effect of thyroid hormones on vasoactive intestinal polypeptide gene expression in the rat cerebral cortex and anterior pituitary
55. Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: Identification of the large molecular form as peptide histidine valine-(1-42)